Share Name Share Symbol Market Type Share ISIN Share Description
Oxford Pharm Gp LSE:OXP London Ordinary Share GB00B3LXPB43 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 1.55p 1.50p 1.60p 1.55p 1.55p 1.55p 0 07:34:43
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.8 -1.9 -0.1 - 18.69

Oxford Pharmascience Group PLC Result of AGM

19/06/2017 11:38am

UK Regulatory (RNS & others)


Oxford Pharm Gp (LSE:OXP)
Historical Stock Chart

1 Month : From May 2017 to Jun 2017

Click Here for more Oxford Pharm Gp Charts.

TIDMOXP

RNS Number : 4736I

Oxford Pharmascience Group PLC

19 June 2017

Oxford Pharmascience Group plc

("Oxford Pharmascience" or the "Company")

Result of AGM

Oxford Pharmascience Group plc (AIM: OXP), the specialty pharmaceutical company that redevelops medicines to make them better, safer and easier to take, is pleased to announce that at its Annual General Meeting held earlier today all resolutions were duly passed.

For further information please contact:

Oxford Pharmascience Group Plc

   Marcelo Bravo, Chief Executive               +44 20 7554 5875 

N+1 Singer (Nominated Adviser & Broker)

   Aubrey Powell/Lauren Kettle                   +44 20 7496 3000 

About Oxford Pharmascience Group Plc

Oxford Pharmascience Group Plc uses a range of proprietary technology platforms to re-develop existing medicines to make them better, safer or easier to take. The Company does not manufacture or sell its own pharmaceutical products direct to consumers, but instead seeks to license its technologies and dossiers to a network of partners, mainly leading pharmaceutical companies with Rx (prescription) and OTC (over the counter) branded portfolios.

Oxford Pharmascience Group Plc focuses on existing medicines that are proven to be safe and effective but nevertheless still have associated issues and side effects often affecting compliance. By working with such medicines, the Company is able to develop new innovative products for a fraction of the cost, in much quicker timescales and without the high risk of failure associated with developing new drugs.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RAGSFWFSUFWSEDM

(END) Dow Jones Newswires

June 19, 2017 06:38 ET (10:38 GMT)

1 Year Oxford Pharm Gp Chart

1 Year Oxford Pharm Gp Chart

1 Month Oxford Pharm Gp Chart

1 Month Oxford Pharm Gp Chart
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:40 V:gb D:20170628 12:32:56